Last update 09 Sep 2026

SLL-022CCP

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
κ opioid receptor
Action
agonists
Mechanism
κ opioid receptor agonists(Kappa opioid receptor agonists)
Therapeutic Areas
Nervous System DiseasesSkin and Musculoskeletal DiseasesOther Diseases
Active Indication
PainPruritus
Inactive Indication-
Originator Organization
Anhui University of Chinese MedicineAnhui University of Chinese MedicineBohai Rim Advanced Research Institute for Drug DiscoveryShanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
Active Organization
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of SciBohai Rim Advanced Research Institute for Drug DiscoveryAnhui University of Chinese MedicineAnhui University of Chinese Medicine
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with SLL-022CCP
Login to view more data
100 Translational Medicine associated with SLL-022CCP
Login to view more data
100 Patents (Medical) associated with SLL-022CCP
Login to view more data
100 Deals associated with SLL-022CCP
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PainPreclinical
China
Bohai Rim Advanced Research Institute for Drug Discovery
04 Jun 2026
PainPreclinical
China
Anhui University of Chinese MedicineAnhui University of Chinese Medicine
04 Jun 2026
PainPreclinical
China
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
04 Jun 2026
PruritusPreclinical
China
Bohai Rim Advanced Research Institute for Drug Discovery
04 Jun 2026
PruritusPreclinical
China
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
04 Jun 2026
PruritusPreclinical
China
Anhui University of Chinese MedicineAnhui University of Chinese Medicine
04 Jun 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free